Clinical Trials · NCT02542930
Abscopal Effect for Metastatic Non-small Cell Lung Cancer.
- Phase
- Phase 2
- Recruitment status
- Withdrawn
- Sponsor
- Zhejiang Provincial People's Hospital
- Enrollment
- 0
- Start date
- Jan 2016
- Locations
- See registry
- Primary endpoint
- The proportion of patients with an abscopal response assessed at 7-8 weeks after the initiation of treatment.